Dermatofibrosarcoma protuberans is a rare skin sarcoma primarily treated by complete resection, with risk factors like tumor size ≥10 cm and surgical margins <3 cm increasing recurrence risk.
This review highlights the importance of distinguishing between low-grade and high-grade fibrosarcomatous DFSP and identifies key risk factors for recurrence and metastasis to guide surgical management.
Dermatofibrosarcoma protuberans (DFSP) is a rare proliferative condition representing skin sarcomas which is known to locally recur yet very rarely metastasizes. Its genetic background is a reciprocal translocation t(17;22)(q22;q13) that produces COL1A1-PDGFB gene fusion. Complete resection is the primary treatment. The aim of this review is to outline the pathogenesis, diagnosis, and management of DFSP. A clear-cut distinction between low-to-moderate-grade DFSP with excellent prognosis and high-grade fibrosarcomatous DFSP with a much worse prognosis is underlined. Malignant transformation within DFSP (or high histologic grade), older age, being female, large primary tumor size (≥10 cm), narrow surgical margins of excision (<3 cm), surgical margin positivity for tumor cells, short time to recurrence, numerous recurrences, tumor that was recently rapidly enlarging, and presence of pain in the tumor have all been proposed as clinicopathological risk factors for recurrence and metastasis. A tendency for local growth and local relapses of well- and moderately differentiated DFSPs is an argument for their surgical excision, possibly combined with reconstructive surgery, even in patients of advanced age. Another main point of this review is that cases of DFSP with fibrosarcomatous transformation are a challenge and require careful medical attention. Both anatomopathological evaluation of the presence of lymphovascular space invasion and sentinel lymph node biopsy at DFSP surgery merit further study.
Jóźwik et al. (Wed,) conducted a review in Dermatofibrosarcoma protuberans. Dermatofibrosarcoma protuberans is a rare skin sarcoma primarily treated by complete resection, with risk factors like tumor size ≥10 cm and surgical margins <3 cm increasing recurrence risk.